| scholarly article | Q13442814 |
| P2093 | author name string | Anne B Sereno | |
| Abigail L Larrison-Faucher | |||
| Anu A Matorin | |||
| P433 | issue | 3 | |
| P921 | main subject | nicotine | Q12144 |
| schizophrenia | Q41112 | ||
| P304 | page(s) | 505-516 | |
| P577 | publication date | 2004-05-01 | |
| P1433 | published in | Progress in Neuro-Psychopharmacology & Biological Psychiatry | Q15616665 |
| P1476 | title | Nicotine reduces antisaccade errors in task impaired schizophrenic subjects | |
| P478 | volume | 28 |
| Q37962995 | A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia |
| Q37127723 | A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia |
| Q48732911 | Attention and memory-related responses of neurons in the lateral intraparietal area during spatial and shape-delayed match-to-sample tasks |
| Q39153464 | Behavioural and computational varieties of response inhibition in eye movements |
| Q36756379 | Cholinergic circuits and signaling in the pathophysiology of schizophrenia |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q91975680 | Differential benefits of olanzapine on executive function in schizophrenia patients: Preliminary findings |
| Q46201976 | Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia |
| Q35202584 | Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study |
| Q30455599 | Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder |
| Q36304346 | Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. |
| Q38171876 | Going up in smoke? A review of nAChRs-based treatment strategies for improving cognition in schizophrenia |
| Q36386392 | Impairment in functional capacity as an endophenotype candidate in severe mental illness. |
| Q36088276 | Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility |
| Q36143799 | Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson's disease |
| Q50737831 | Neural correlates of impaired volitional action control in schizophrenia patients. |
| Q60046151 | Neurobiological Determinants of Tobacco Smoking in Schizophrenia |
| Q30491325 | Neurophysiological endophenotypes of schizophrenia: the viability of selected candidate measures |
| Q33644537 | Nicotine consumption and schizotypy in first-degree relatives of individuals with schizophrenia and non-psychiatric controls |
| Q56992145 | Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy |
| Q51260569 | Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls. |
| Q36917265 | Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function |
| Q59050953 | Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison |
| Q35173870 | Pharmacological treatment effects on eye movement control |
| Q34002872 | Schizophrenia and the alpha7 nicotinic acetylcholine receptor |
| Q30491841 | Smoking, Genetics and Schizophrenia: Evidence for Self Medication |
| Q51980369 | The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine. |
| Q36965847 | The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues |
| Q37308096 | The tell-tale tasks: a review of saccadic research in psychiatric patient populations |
| Q90314437 | To look or not to look? Reward, selection history, and oculomotor guidance |
| Q30407039 | Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation |
Search more.